Podduturu Reddy
Pulmonary Disease · Port Huron, MINPI 1003816331
Payments from drug & device makers
Across 803 payments — averaging $418.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$173K
- Genentech USA, Inc.$114K
- Amgen$19K
- Regeneron Healthcare Solutions, Inc.$18K
- Sanofi$4K
- Novartis$3K
- plus $5K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 288 | $173,257 |
| Genentech USA, Inc. | 154 | $114,438 |
| Amgen | 74 | $19,152 |
| Regeneron Healthcare Solutions, Inc. | 38 | $17,715 |
| Sanofi | 17 | $3,859 |
| Novartis | 15 | $2,705 |
| Takeda Pharmaceuticals U.S.A., Inc. | 59 | $1,230 |
| CSL Behring | 32 | $694 |
| Grifols USA, LLC | 28 | $553 |
| GSK | 18 | $274 |
| Veran Medical Technologies, Inc. | 2 | $178 |
| Harmony Biosciences LLC | 8 | $166 |
| Actelion Pharmaceuticals US, Inc. | 7 | $156 |
| Merck | 7 | $143 |
| Vifor Pharma, Inc. | 6 | $128 |
| Johnson & Johnson | 1 | $120 |
| Shire North American Group Inc | 6 | $106 |
| Insmed, Inc. | 7 | $106 |
| United Therapeutics Corporation | 5 | $103 |
| Insulet Corporation | 1 | $100 |
| Pfizer | 5 | $99 |
| Boehringer Ingelheim | 4 | $86 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Mylan Specialty L.p. | 3 | $40 |
| AbbVie | 1 | $33 |
| Philips North America LLC | 2 | $31 |
| Gilead | 2 | $28 |
| Electromed, Inc. | 1 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $15 |
| Inogen, Inc. | 1 | $14 |
| Advanced Respiratory, Inc | 1 | $13 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
| Pulmonx Corporation | 1 | $13 |
How this compares
$335,729 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Port Huron
- Njira LugogoAnn Arbor$12.9M
- Timothy BlackwellAnn Arbor$2.5M
- Kevin FlahertyAnn Arbor$2.3M
- Meilan HanAnn Arbor$1.8M
- Gary FergusonLivonia$1.5M
- Justin OldhamAnn Arbor$1.4M
- Robert PaineAnn Arbor$1.3M
- Irina ShanidzeFarmington Hills$1.2M
- Oscar Parodi Ortiz de VillateWarren$1.1M
- Yvonne HuangAnn Arbor$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.